CompaniesByCap
CRSP
Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare

Crispr Therapeutics AG Income Statement 2015–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Revenues
Revenue3.5M37.3M371.2M1.2M915.0M719,000289.6M3.1M41.0M5.2M247,000
Gross Profit
Profitability
Operating Income-664.6M-466.6M-222.5M-673.2M373.5M-354.4M46.7M-158.9M-64.6M-68.1M-25.7M
EBITDA-645.1M-447.3M-202.7M-649.0M391.5M-345.3M51.5M-155.4M-61.6M-67.2M-25.6M
Net Income-581.6M-366.3M-153.6M-650.2M377.7M-348.9M66.9M-165.0M-68.4M-23.2M-25.5M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)90M84M79M78M80M66M57M48M40M40M6M

Crispr Therapeutics AG Income Statement — FAQ

Crispr Therapeutics AG (CRSP) income statement over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CRSP's income statement history?

The chart and table above show Crispr Therapeutics AG's income statement by year and by quarter, including the growth rate.